Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Epilepsy Research|May 4, 2004
Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticusAndrey M Mazarati, Roger Baldwin, Henrik Klitgaard, et al.
Epilepsy Research|November 17, 2009
Brivaracetam (ucb 34714) inhibits Na(+) current in rat cortical neurons in cultureCristina Zona, Massimo Pieri, Irene Carunchio, et al.
Epilepsia|August 30, 2017
Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neuronsIsabelle Niespodziany, Jean-Michel Rigo, Gustave Moonen, et al.
European Journal of Pharmacology|July 25, 2003
Antihyperalgesic effect of levetiracetam in neuropathic pain models in ratsDenis Ardid, Yves Lamberty, Abdelkrim Alloui, et al.
Neuroreport|March 14, 2003
Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neuronsMikael Angehagen, Doru Georg Margineanu, Elinor Ben-Menachem, et al.
European Journal of Pharmacology|April 23, 2009
Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsyAlain Matagne, Doru-Georg Margineanu, Heidrun Potschka, et al.
Frontiers in Pharmacology|August 9, 2024
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implicationsClara Mayer, Lluís Riera-Ponsati, Sakari Kauppinen, et al.
European Journal of Pharmacology|October 14, 2003
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell linesBruno Fuks, Michel Gillard, Philippe Michel, et al.
Neuropharmacology|August 28, 2003
Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?Michael Madeja, Doru Georg Margineanu, Ali Gorji, et al.
Pageof 6